CLL Therapy Approaches in Russia

Clinical trial NCT05140369 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05140369
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2021-10-29
Primary completion: 2027-03-31
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.